Published in J Clin Microbiol on December 01, 1994
A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva. Invest Ophthalmol Vis Sci (2009) 0.94
Herpes simplex virus reactivation and dental procedures. Clin Oral Investig (2013) 0.86
HSV-1 latent rabbits shed viral DNA into their saliva. Virol J (2012) 0.82
Herpes simplex meningitis after surgical removal of a clivus chordoma. Eur J Clin Microbiol Infect Dis (1997) 0.75
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J Gen Virol (1984) 2.22
Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J Infect Dis (1991) 2.06
Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med (1979) 1.61
Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet (1991) 1.60
More rapid isolation of herpes simplex virus in a continuous line of mink lung cells than in Vero or human fibroblast cells. Diagn Microbiol Infect Dis (1984) 1.39
The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. J Infect Dis (1991) 1.34
Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J Infect Dis (1978) 1.32
An alternative theory of herpes-simplex recurrence and a possible role for prostaglandins. Lancet (1976) 1.28
UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovir. J Infect Dis (1992) 0.92
Rapid detection of human herpes simplex virus type 1 in saliva. Arch Oral Biol (1992) 0.83
Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med (1973) 5.66
Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun (1980) 5.03
Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med (1974) 4.49
The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med (1977) 3.61
Theiler's virus persists in glial cells during demyelinating disease. Cell (1981) 2.67
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun (1981) 2.49
Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect Immun (1983) 2.21
Giant axonal neuropathy--a unique case with segmental neurofilamentous masses. Acta Neuropathol (1972) 1.91
The course of untreated recurrent genital herpes simplex infection in 27 women. N Engl J Med (1981) 1.89
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
The structural polypeptides of RNA slow viruses. Virology (1974) 1.81
Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis (1982) 1.72
Experimental herpes simplex encephalitis: early neuropathologic changes. J Neuropathol Exp Neurol (1970) 1.65
Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread. Infect Immun (1979) 1.58
Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection. Arch Dermatol (2001) 1.54
Herpes simplex virus infection of nervous tissue in animals and man. Prog Med Virol (1975) 1.52
Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis (2000) 1.51
Sensory perineuritis. Arch Neurol (1972) 1.51
Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol (1975) 1.44
Detection of Theiler's virus RNA in mouse central nervous system by in situ hybridization. Lab Invest (1981) 1.43
Partial purification and evidence for multiple molecular forms of the scrapie agent. Biochemistry (1978) 1.42
A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Arch Dermatol (1998) 1.39
Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection. Antimicrob Agents Chemother (1984) 1.37
The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. J Infect Dis (1991) 1.34
Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol (1998) 1.32
An acute syndrome of ocular oscillations and truncal myoclonus. Brain (1968) 1.31
Tubular aggregates in endoplasmic reticulum in herpes-simplex encephalitis. N Engl J Med (1971) 1.29
Progressive rubella panencephalitis. Late onset after congenital rubella. N Engl J Med (1975) 1.28
Chronic hypoventilation of central origin. A case with encephalitis lethargica and Parkinson's syndrome. Am Rev Respir Dis (1967) 1.28
Tubular aggregates in endoplasmic reticulum: evidence against their viral nature. J Ultrastruct Res (1972) 1.23
Virus-like particles and nucleoprotein-type filaments in brain tissue from two patients with Creutzfeldt-Jakob disease. Lancet (1970) 1.21
The numb chin in metastatic cancer. West J Med (1991) 1.16
Pathogenesis of recurrent herpes simplex labialis. IV. Maturation of lesions within 8 hours after onset and implications for antiviral treatment. Oral Surg Oral Med Oral Pathol (1984) 1.12
Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir. Antimicrob Agents Chemother (1984) 1.12
Failure of topical acyclovir in ointment to penetrate human skin. Antimicrob Agents Chemother (1986) 1.09
Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment. Ann Neurol (1983) 1.08
Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity. J Clin Microbiol (1984) 1.08
Clinical and virologic course of herpes simplex genitalis. West J Med (1979) 1.07
Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis. N Engl J Med (1979) 1.07
Radioimmunoassay of herpes simplex virus antibody: correlation with ganglionic infection. J Gen Virol (1977) 1.07
Chronic arthropathy associated with rubella vaccination. Arthritis Rheum (1977) 1.07
Persistent herpes simplex virus infection in rabbit trigeminal ganglia. Lab Invest (1974) 1.05
Typing of herpes simplex virus with type-specific human immunoglobulin M in an indirect immunofluorescence assay. J Clin Microbiol (1982) 1.05
The significance of giant vacuolation of endoneurial fibroblasts. Acta Neuropathol (1971) 1.05
Ultrastructure of mumps virus replication in newborn hamster central nervous system. Lab Invest (1974) 1.04
The neuropathology of progressive rubella panencephalitis of late onset. Brain (1976) 1.04
Viral-induced leukocyte interferon in vesicle fluid from lesions of recurrent herpes labialis. J Infect Dis (1981) 1.03
Experimental scrapie in mice: ultrastructural observations. Ann Neurol (1978) 1.02
Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation. J Infect Dis (1997) 1.02
Joint complications associated with derivatives of HPV-77 rubella virus vaccine. Am J Dis Child (1971) 1.02
The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol (1992) 1.00
Th1/Th2-like immunity and resistance to herpes simplex labialis. Antiviral Res (1995) 1.00
Herpetic proctitis and meningitis: recovery of two strains of herpes simplex virus type 1 from cerebrospinal fluid. J Infect Dis (1982) 0.99
Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis (1990) 0.98
Persistent, slow and latent viral infections. Prog Med Virol (1982) 0.96
Pathogenesis of herpes simplex labialis: experimental induction of lesions with UV light. J Clin Microbiol (1985) 0.96
Post-herpetic erythema multiforme prevented with prophylactic oral acyclovir. Ann Intern Med (1985) 0.96
Morphology of central nervous system disease in immunosuppressed mice after peripheral herpes simplex virus inoculation. Trigeminal root entry zone. Lab Invest (1979) 0.95
The histopathologic evolution of recurrent herpes simplex labialis. J Am Acad Dermatol (1981) 0.95
Detection of tissue culture-adapted Theiler's virus RNA in spinal cord white matter cells throughout infection. Infect Immun (1982) 0.95
Delayed stroke following carotid occlusion. Neurology (1980) 0.94
Central nervous system susceptibility to herpes simplex infection. J Neuropathol Exp Neurol (1978) 0.94
Neuronal reactivation of herpes simplex virus may involve interleukin-6. J Neurovirol (1997) 0.93
Experimental herpes simplex encephalitis. Treatment with pyrimidine nucleosides. Arch Neurol (1973) 0.93
Efficacy of topical treatment for herpes simplex virus infections: predictions from an index of drug characteristics in vitro. J Infect Dis (1986) 0.93
Scrapie-associated particles in postsynaptic processes. Further ultrastructural studies. J Neuropathol Exp Neurol (1981) 0.93
Cortical MRI findings associated with rapid correction of hyponatremia. Neurology (2000) 0.92
Susceptibility to herpes labialis following multiple experimental exposures to ultraviolet radiation. Antiviral Res (1995) 0.92
Biochemistry of Theiler's murine encephalomyelitis virus isolated from acutely infected mouse brain: identification of a previously unreported polypeptide. Infect Immun (1981) 0.91
Experimental measles virus encephalitis. A light, phase, fluorescence, and electron microscopic study. Lab Invest (1970) 0.91
Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer. Infect Immun (1982) 0.91
Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream. Antiviral Res (1985) 0.90
Progressive myelopathy due to extramedullary hematopoiesis: case report and review of the literature. Ann Neurol (1979) 0.90
Scrapie infection diminishes spines and increases varicosities of dendrites in hamsters: a quantitative Golgi analysis. J Neuropathol Exp Neurol (1987) 0.90
Pathogenesis of herpes simplex labialis. I. Replication of herpes simplex virus in cultures of epidermal cells from subjects with frequent recurrences. J Infect Dis (1980) 0.90
Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol (1989) 0.90
Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J Infect Dis (1976) 0.89
Latent period of 53 years in a case of hydatid cyst disease. Arch Intern Med (1974) 0.89
Progressive retinal degeneration in scrapie-infected hamsters: a light and electron microscopic analysis. Lab Invest (1981) 0.89
Growth of Newcastle disease virus and rubella virus in rheumatoid and nonrehumatoid synovial cell cultures. Infect Immun (1972) 0.89
Nocardial cerebral abscess in the acquired immunodeficiency syndrome. Arch Neurol (1987) 0.89
Neuropathology of progressive rubella panencephalitis after childhood rubella. Neurology (1982) 0.89
Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: a pilot study. J Infect Dis (2000) 0.88
Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis. Antimicrob Agents Chemother (1992) 0.88
Chronic meningitis caused by Propionibacterium acnes. A potentially important clinical entity. Neurology (1974) 0.88
A simplified procedure for spinal fluid cytology. Arch Neurol (1970) 0.88
Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J Infect Dis (1996) 0.88
Replication of the scrapie agent in hamster brain precedes neuronal vacuolation. J Neuropathol Exp Neurol (1983) 0.88
Recombinant human interferon-alpha A treatment of an experimental cutaneous herpes simplex virus type 1 infection of guinea pigs. J Interferon Res (1987) 0.88
Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit. Am J Med (1982) 0.88
Experimental herpes simplex virus encephalitis. Effect of corticosteroids and pyrimidine nucleoside. Arch Neurol (1976) 0.87
Reovirus-induced aqueductal stenosis in hamsters. Phase contrast and electron microscopic studies. Lab Invest (1972) 0.87
Immunochemical features of a case of progressive rubella panencephalitis. Clin Exp Immunol (1982) 0.87
A new look at mumps encephalitis: inclusion bodies and cytopathic effects. J Neuropathol Exp Neurol (1974) 0.86
Value of open-lung biopsy in 87 immunocompromised patients with pulmonary infiltrates. Cancer (1985) 0.86
Effect of azone and propylene glycol on penetration of trifluorothymidine through skin and efficacy of different topical formulations against cutaneous herpes simplex virus infections in guinea pigs. Antimicrob Agents Chemother (1984) 0.86
Herpes simplex virus and Bell palsy. Ann Intern Med (1996) 0.86
Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrob Agents Chemother (2002) 0.86